PharmaCyte Biotech, Inc. PMCB US Equity
$0.52
-0.03 (-4.66%)
USD · as of 2026-08-28 · marketstack
PharmaCyte Biotech, Inc. (Nasdaq: PMCB), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $0.52, -4.7%, on 2026-08-28, with a market cap of $6M, a trailing P/E of 0.2 and a return on equity of 77.1%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 208K |
| % of shares out | 1.9% |
| Days to cover | 2.1 |
| Δ vs 2026-07-31 | -28.7% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.